How to legally get Ozempic online in California

In the evolving landscape of weight management treatments, GLP-1 medications like Wegovy, Ozempic, and Mounjaro have emerged as game-changers. But can you access these medications through telehealth services? The short answer is yes—in most states, you can legally get these weight loss medications through telehealth, though specific requirements vary by location.

Understanding Telehealth Access to GLP-1 Medications

GLP-1 agonists (semaglutide and tirzepatide) are not controlled substances, which means they don’t fall under the strict federal in-person visit requirements that apply to medications like Adderall or Xanax. This makes them generally accessible through telehealth platforms across the country.

However, navigating state-specific regulations can be confusing. Some states have additional requirements for prescribing weight loss medications, while others have embraced telehealth with minimal restrictions.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Rules for Weight Loss Medications

At the federal level, there are no restrictions preventing licensed healthcare providers from prescribing GLP-1 medications via telehealth. The Ryan Haight Act’s in-person requirements only apply to controlled substances, not to medications like Wegovy or Ozempic.

This means that as long as a proper patient-provider relationship is established through a legitimate telehealth consultation, these medications can be prescribed remotely under federal law.

State-by-State Telehealth Rules for Weight Loss Medications

States with Minimal Telehealth Restrictions

These states allow full telehealth prescribing of GLP-1s without requiring an in-person visit:

• California: Embraces telehealth fully; no in-person exam required
• Connecticut: Allows telehealth prescribing with behavioral counseling requirements
• Florida: Permits telehealth prescribing but requires BMI ≥30 and follow-ups every 3 months
• Illinois: No special restrictions on telehealth weight loss prescriptions
• New York: Fully permits telehealth prescribing with no in-person requirements
• Pennsylvania: No special telehealth barriers for GLP-1 prescriptions
• Washington: Pioneer in telehealth access with strong patient privacy protections

States Requiring an Initial In-Person Visit

These states generally require an initial face-to-face examination before telehealth can be used for ongoing care:

• Arkansas: Initial in-person exam required before telehealth prescribing
• Delaware: First examination must be conducted in person
• Georgia: Initial in-person evaluation required for weight management therapy
• Mississippi: State law requires an initial in-person evaluation
• New Jersey: Comprehensive in-person exam and labs required initially
• North Dakota: Hands-on initial evaluation expected for weight loss treatment
• South Carolina: Must examine patient in person first
• Texas: Initial in-person exam generally expected prior to telehealth prescribing
• Utah: Initial in-person exam encouraged
• Virginia: Must perform physical exam and labs initially

Who Can Prescribe GLP-1s via Telehealth?

The qualifications of who can prescribe these medications vary by state:

States with Independent NP Practice Authority

In these states, Nurse Practitioners can prescribe GLP-1s without physician oversight (after meeting experience requirements in some cases):

• California, Connecticut, New York, North Dakota, Utah, Virginia, Washington

States Requiring Collaborative Practice

In these states, NPs and PAs must have some form of physician agreement or supervision:

• Arkansas, Delaware, Florida, Georgia, Illinois, Mississippi, New Jersey, Pennsylvania, South Carolina, Texas

This is important because many telehealth platforms employ both physicians and advanced practice providers, and the rules governing who can prescribe may affect your care options.

What to Expect in a Legitimate Telehealth Consultation

A reputable telehealth provider like Klarity Health will conduct a comprehensive evaluation that includes:

1. Medical history review: Including current medications, allergies, and previous weight loss attempts
2. BMI verification: Most providers require a BMI ≥30, or ≥27 with weight-related comorbidities
3. Screening for contraindications: Including pregnancy, personal/family history of medullary thyroid carcinoma, and other conditions that would make GLP-1s unsafe
4. Discussion of lifestyle changes: Diet and exercise recommendations to accompany medication
5. Informed consent: Reviewing potential side effects and realistic expectations
6. Regular follow-ups: Typically monthly at first, then every 2-3 months

Red Flags to Watch For When Seeking Telehealth Weight Loss Treatment

Not all telehealth providers offer the same quality of care. Be cautious of services that:

• Guarantee a prescription without a thorough evaluation
• Offer compounded or overseas versions of semaglutide (the FDA banned most compounding in 2025)
• Don’t require follow-up appointments
• Lack transparency about provider credentials
• Skip discussing risks, side effects, and alternatives
• Request you to waive your rights or seem to lack legitimate business information

How Klarity Health Ensures Safe, Legal Access to Weight Loss Medications

At Klarity Health, we prioritize both accessibility and safety in our telehealth weight management program. Our approach includes:

• Comprehensive initial evaluations with licensed providers in your state
• Clear documentation of medical necessity based on clinical guidelines
• Regular follow-up appointments to monitor progress and side effects
• Transparent pricing with both insurance and self-pay options
• Prescriptions sent electronically to your preferred pharmacy
• Ongoing support and lifestyle modification guidance

We ensure all our providers are properly licensed in your state and follow all applicable regulations, giving you peace of mind that your treatment is both legal and medically sound.

The Future of Telehealth for Weight Loss Medications

Telehealth access to GLP-1 medications is here to stay, though regulations continue to evolve. Key trends to watch:

• More states moving toward telehealth-friendly policies
• Increasing insurance coverage for both telehealth visits and GLP-1 medications
• Growing recognition of telehealth’s role in addressing obesity as a chronic disease
• Potential standardization of telehealth regulations across states

For patients seeking weight management support, telehealth offers a convenient, discrete option that eliminates many traditional barriers to care.

Conclusion: Finding the Right Telehealth Provider for Your Weight Loss Journey

If you’re considering GLP-1 medications for weight management, telehealth can be a legitimate, convenient option in most states. The key is finding a reputable provider that follows all applicable regulations while delivering high-quality care.

Klarity Health connects patients with licensed providers who can evaluate your situation, determine if GLP-1 therapy is appropriate, and provide ongoing support throughout your weight loss journey—all while navigating the complex regulatory landscape on your behalf.

Ready to explore whether GLP-1 medications might be right for you? Schedule a telehealth consultation today to discuss your options with a licensed healthcare provider who understands both the medical and regulatory aspects of weight management treatment.

Citations

1. ‘DEA and HHS Extend Telemedicine Flexibilities through 2025.’ DEA.gov, November 15, 2024.

2. ‘The Drug Enforcement Administration extends COVID-era telehealth prescribing flexibilities through 2025.’ Axios, November 18, 2024.

3. ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025.’ McDermott Will & Emery, November 18, 2024.

4. ‘Changing Regulatory & Reimbursement Landscape for Weight Loss Drugs.’ Goodwin Law, March 27, 2024.

5. ‘Telehealth company Hims & Hers Health to cut 4% of workforce amid ban on weight-loss drug copies.’ Reuters, May 30, 2025.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid